• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺化生性癌。IV. 导管源性鳞状细胞癌。

Metaplastic carcinomas of the breast. IV. Squamous cell carcinoma of ductal origin.

作者信息

Wargotz E S, Norris H J

机构信息

Department of Breast and Gynecologic Pathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000.

出版信息

Cancer. 1990 Jan 15;65(2):272-6. doi: 10.1002/1097-0142(19900115)65:2<272::aid-cncr2820650215>3.0.co;2-6.

DOI:10.1002/1097-0142(19900115)65:2<272::aid-cncr2820650215>3.0.co;2-6
PMID:2153044
Abstract

The clinical and pathologic features of 22 examples of pure ductal squamous cell carcinoma (SqCC) of the breast are reported. All patients were women with a mean age of 53 years. Only two of the 19 women with axillary dissection had metastases, but one woman had a positive supraclavicular lymph node in the presence of negative axillary nodes. All metastases were squamous carcinoma. All patients were eligible for a minimum of 5 years' follow-up; the cumulative 5-year disease-specific survival rate was 63%. Eight women developed metastases and one also developed local recurrence, all within 2 years, and all eight died from tumor within 4 years of initial therapy (mean, 2 years). Prophylactic postoperative radiation therapy and radiation for lymph node metastases at initial surgery did not prolong survival as four of the five recipients died from tumor. Although there were no statistically significant gross or histologic differences between recurrent and nonrecurrent neoplasms, larger neoplasms tended to metastasize. Immunohistochemical study for S-100 protein identified an immunoreactive cell component in five of seven neoplasms tested. This and light microscopic findings suggest myoepithelial proliferation, differentiation, or origin.

摘要

报告了22例乳腺单纯导管鳞状细胞癌(SqCC)的临床和病理特征。所有患者均为女性,平均年龄53岁。19例行腋窝清扫术的女性中只有2例发生转移,但有1名女性在腋窝淋巴结阴性的情况下出现锁骨上淋巴结阳性。所有转移灶均为鳞状细胞癌。所有患者均至少随访5年;5年累积疾病特异性生存率为63%。8名女性发生转移,1名还出现局部复发,均在2年内发生,且所有8名患者在初始治疗后4年内死于肿瘤(平均2年)。预防性术后放疗以及初始手术时对淋巴结转移灶的放疗均未延长生存期,因为5名接受放疗的患者中有4名死于肿瘤。尽管复发肿瘤与未复发肿瘤之间在大体或组织学上无统计学显著差异,但较大的肿瘤更易发生转移。对7例肿瘤进行的S-100蛋白免疫组化研究显示,其中5例存在免疫反应性细胞成分。这一结果以及光镜检查结果提示肌上皮细胞增殖、分化或起源。

相似文献

1
Metaplastic carcinomas of the breast. IV. Squamous cell carcinoma of ductal origin.乳腺化生性癌。IV. 导管源性鳞状细胞癌。
Cancer. 1990 Jan 15;65(2):272-6. doi: 10.1002/1097-0142(19900115)65:2<272::aid-cncr2820650215>3.0.co;2-6.
2
Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.经乳房钼靶检查发现、临床隐匿的导管原位癌,采用保乳手术及根治性乳房放疗进行治疗。
Cancer J Sci Am. 1996 May-Jun;2(3):158-65.
3
Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.早期乳腺癌保乳手术及放疗后的局部复发和远处转移
Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):25-38. doi: 10.1016/s0360-3016(98)00365-4.
4
Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment.采用保乳手术和根治性放疗治疗的乳腺导管原位癌(导管内癌)。病理参数与治疗结果的相关性。
Cancer. 1993 Apr 15;71(8):2532-42. doi: 10.1002/1097-0142(19930415)71:8<2532::aid-cncr2820710817>3.0.co;2-0.
5
Tubular carcinoma of the breast: an institutional experience and review of the literature.乳腺小管癌:机构经验及文献综述
Breast J. 2003 Jul-Aug;9(4):298-301. doi: 10.1046/j.1524-4741.2003.09409.x.
6
Positive versus negative sentinel nodes in early breast cancer patients: axillary or loco-regional relapse and survival. A study spanning 2000-2012.早期乳腺癌患者的前哨淋巴结阳性与阴性:腋窝或局部区域复发和生存。一项跨越 2000-2012 年的研究。
Breast. 2013 Oct;22(5):902-7. doi: 10.1016/j.breast.2013.04.015. Epub 2013 May 15.
7
Metaplastic carcinomas of the breast. III. Carcinosarcoma.乳腺化生性癌。III. 癌肉瘤。
Cancer. 1989 Oct 1;64(7):1490-9. doi: 10.1002/1097-0142(19891001)64:7<1490::aid-cncr2820640722>3.0.co;2-l.
8
Clinicopathologic analysis of a large series of microinvasive breast cancers.大量微浸润性乳腺癌的临床病理分析
Breast J. 2018 Jul;24(4):574-579. doi: 10.1111/tbj.13001. Epub 2018 Feb 24.
9
Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature.乳腺化生性癌,一种预后较差的罕见疾病:欧洲肿瘤研究所的经验及文献综述
Breast Cancer Res Treat. 2007 Mar;101(3):349-53. doi: 10.1007/s10549-006-9301-1. Epub 2006 Sep 29.
10
Radiation therapy for intraductal carcinoma. Is it an equal alternative?
Arch Surg. 1991 Apr;126(4):424-8.

引用本文的文献

1
Survival of patients with squamous cell carcinoma of the breast compared with invasive ductal carcinoma by biological subtype: A matched analysis of the Japanese national clinical database-breast cancer registry.乳腺鳞状细胞癌与浸润性导管癌患者按生物学亚型的生存率比较:日本国家临床数据库-乳腺癌登记处的配对分析。
Breast. 2025 Aug 27;83:104567. doi: 10.1016/j.breast.2025.104567.
2
Clinical Implication of Subcategorizing T2 Category in Metaplastic Breast Cancer.化生性乳腺癌中T2亚分类的临床意义
J Breast Cancer. 2025 Jun;28(3):193-205. doi: 10.4048/jbc.2025.0032.
3
Metaplastic Breast Cancer: A Case Report on a Rare Neoplasm of the Breast.
化生性乳腺癌:一例罕见乳腺肿瘤的病例报告
Cureus. 2024 Jul 2;16(7):e63717. doi: 10.7759/cureus.63717. eCollection 2024 Jul.
4
Breast Conservation Therapy for Primary Squamous Cell Carcinoma of the Breast in an Elderly Woman: A Case Report.老年女性原发性乳腺鳞状细胞癌的保乳治疗:一例报告
Cureus. 2024 May 1;16(5):e59447. doi: 10.7759/cureus.59447. eCollection 2024 May.
5
Translational Aspects in Metaplastic Breast Carcinoma.化生性乳腺癌的转化研究方面
Cancers (Basel). 2024 Apr 7;16(7):1433. doi: 10.3390/cancers16071433.
6
Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy.针对间充质三阴性乳腺癌化疗耐药性:一项新辅助血管生成和mTOR抑制联合化疗的II期试验
Invest New Drugs. 2023 Jun;41(3):391-401. doi: 10.1007/s10637-023-01357-4. Epub 2023 Apr 12.
7
Targeted therapy combined with immunotherapy in patients with breast infiltrating ductal carcinoma with axillary lymph node metastasis of metaplastic SCC.针对伴有转移性梭形细胞癌的腋窝淋巴结转移的乳腺浸润性导管癌患者的靶向治疗联合免疫治疗。
Thorac Cancer. 2022 Oct;13(19):2799-2807. doi: 10.1111/1759-7714.14602. Epub 2022 Aug 16.
8
The Effect of HER2 Status on Metaplastic Breast Cancer A Propensity Score-Matched Analysis.HER2 状态对化生性乳腺癌的影响:倾向评分匹配分析。
Front Endocrinol (Lausanne). 2022 Jun 16;13:874815. doi: 10.3389/fendo.2022.874815. eCollection 2022.
9
The Effect of Post-Mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: A Propensity Score-Matched Analysis of the SEER Database.保乳术后放疗对化生性乳腺癌患者的影响:基于监测、流行病学和最终结果(SEER)数据库的倾向评分匹配分析
Front Oncol. 2022 Jan 12;11:593121. doi: 10.3389/fonc.2021.593121. eCollection 2021.
10
Pathological Complete Response to Neoadjuvant Chemotherapy in a Patient with HER2-Positive Squamous Cell Carcinoma of the Breast.1例HER2阳性乳腺鳞状细胞癌患者对新辅助化疗的病理完全缓解
Case Rep Oncol. 2021 Oct 22;14(3):1536-1541. doi: 10.1159/000519746. eCollection 2021 Sep-Dec.